摘要
神经母细胞瘤(Neuroblastoma,NB)是小儿最常见的颅外实体肿瘤,Ⅳ期NB长期无病生存率仍低于30%。为此我们综合了发达国家的经验,并结合我国国情,制定了NB诊断治疗综合方案,以期改善我国儿童NB的预后。该方案实施近10年,至2005年12月31日共收治Ⅳ期NB患儿69例,现报告如下。
出处
《中华儿科杂志》
CAS
CSCD
北大核心
2009年第3期225-227,共3页
Chinese Journal of Pediatrics
参考文献14
-
1Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment. J Clin Oncol, 1993,11 : 1466-1477.
-
2London WB, Boni L, Simon T, et al. The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. Cancer Lett, 2005,228:257-266.
-
3Pearson AD, Pinkerton CR, Lewis IJ, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol, 2008, 9:247-256.
-
4Valteau-Couanet D, Michon J, Boneu A, et al. Resuhs of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oneology (SFOP) protocol, J Clin Oneol, 2005,23:532-540.
-
5Frappaz D, Michon J, Coze C, et al. LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol, 2000,18: 468 -476.
-
6Kaneko M, Tsuchida Y, Mugishima H, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol, 2002 ,24:613-621.
-
7McGregor LM, Rao BN, Davidoff AM, et al. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience. Cancer, 2005,104:2837-2846.
-
8Sung KW, Lee SH, Yoo KH, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma. Bone Marrow Transplant, 2007, 40:37-45.
-
9Schmidt ML, Lal A, Seeger RC, et al. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. J Clin Oncol, 2005,23:6474-6480.
-
10George RE, London WB, Cohn SL, et al. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol, 2005,23:6466-6473.
同被引文献20
-
1谢华,陈方,张忠德,徐卯升,耿红全.原发性睾丸旁神经母细胞瘤一例[J].中华医学杂志,2006,86(5):360-360. 被引量:1
-
2Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma [J]. Lancet, 2007, 369(9579): 2106-2120.
-
3Peuehmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in gan- glioneuroblastoma, nodular[J]. Cancer, 2003, 98 (10) : 2274-2281.
-
4Koseoglu V, Akata D, Kutluk T, et al. Neuroblastoma with spermatic cord metastasis in a child: sonographic findings[J]. J Clin Ultrasound, 1999, 27(5) : 287-289.
-
5Haupt R, Garaventa A, Gambini C, et al. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian neuroblastoma registry [J]. J Clin Oncol, 2010, 28(14): 2331-2338.
-
6Aydn GB, Kutluk MT, Yalcn B, et al. Neuroblastoma in Turkish children: experience of a single center[J]. J Pediatr Hematol Oneol, 2009, 31(7): 471-480.
-
7殷敏智,张忠德,马靖,沈萍,陈洁枫,张惠箴.外周神经母细胞性肿瘤135例分类与预后的关系[J].中华病理学杂志,2011,40(3):151-155. 被引量:10
-
8吉毅,肖现民.神经母细胞瘤的研究与治疗现状[J].中华小儿外科杂志,2011,32(9):703-706. 被引量:5
-
9Larry Wang,何乐健,Hiroyuki Shimada.外周神经母细胞性肿瘤临床病理特点[J].中华病理学杂志,2012,41(4):283-288. 被引量:13
-
10刘炜,周崇臣,田亮,毛彦娜,邹旭凤.儿童神经母细胞瘤22例临床分析[J].白血病.淋巴瘤,2012,21(9):550-551. 被引量:2
引证文献3
-
1陈卫坚,周峥珍,刘敏,张丽琼,姜楠.神经母细胞瘤体表转移14例临床病理分析[J].中华小儿外科杂志,2015,36(1):17-20. 被引量:1
-
2肖慧,郭霞,万智,艾媛,杨雪,孙舒雯,蒋呜艳,高举.儿童神经母细胞性肿瘤的临床特征及预后分析的单中心研究[J].国际输血及血液学杂志,2017,40(5):378-386. 被引量:7
-
3苏雁,马晓莉,王焕民,秦红,秦茂权,张福泉,金眉,张大伟,陈诚豪,曾骐,何乐建,倪鑫.单中心458例高危神经母细胞瘤患儿临床特征及预后分析[J].中华儿科杂志,2020,58(10):796-798. 被引量:15
二级引证文献23
-
1于山.CT及MRI对中枢神经系统神经母细胞瘤的诊断价值[J].中国CT和MRI杂志,2018,16(10):19-21. 被引量:6
-
2祁文清,陈依君,陈凯.心理支持及认知干预在腹膜后恶性肿瘤患儿围手术期应用的研究[J].癌症进展,2019,17(4):490-493. 被引量:9
-
3谢国斌,胡高峰.MRI与CT检查在中枢神经系统神经母细胞瘤诊断中的价值比较[J].中国基层医药,2019,26(13):1607-1610. 被引量:2
-
4张大,李梦娇,杨林.α-地中海贫血/精神发育迟滞综合征X染色体相关基因蛋白表达对儿童神经母细胞瘤预后的影响[J].肿瘤基础与临床,2020,33(3):188-190. 被引量:1
-
5朱呈光,贺湘玲,汤止戈,陈可可,邹润英,田鑫,游亚兰.44例儿童神经母细胞瘤临床分析[J].中国当代儿科杂志,2020,22(11):1193-1197. 被引量:7
-
6李健,孙小兵,代晋宇,童风玲.血清神经元特异性烯醇化酶在神经母细胞瘤患儿诊断中的应用价值[J].中国基层医药,2020,27(22):2749-2752. 被引量:2
-
7杨小英,徐昕,杜雨香,冶文千,魏晓明.CT对儿童纵隔神经母细胞瘤与节细胞神经母细胞瘤的鉴别诊断[J].实用放射学杂志,2021,37(7):1165-1168. 被引量:3
-
8邢天禹,陈慧,高超,陈振萍,贺思豆,苏雁,马晓莉.应用流式细胞术辅助诊断神经母细胞瘤患儿骨髓侵犯[J].临床检验杂志,2021,39(9):646-649.
-
9冯楚础,黎阳,邬萍萍,熊稀霖,彭晓敏,翁文骏.儿童神经母细胞瘤骨髓微小残留病变的临床意义分析[J].中国小儿血液与肿瘤杂志,2021,26(5):301-304.
-
10刘涛,盛庆丰,刘江斌,徐伟珏,蒋莎义,杨秀军,吕志宝.INSS 4期神经母细胞瘤患儿3年无事件生存率的相关因素分析[J].临床小儿外科杂志,2022,21(2):121-127. 被引量:5
-
1赵强,张广超,陈鸿骏,闫杰,李璋林,曹嫣娜.Ⅲ、Ⅳ期神经母细胞瘤治疗的临床体会[J].中国肿瘤临床,2002,29(6):416-417. 被引量:2
-
2孙立荣,庞秀英,李学荣,卢愿.维甲酸联合干扰素治疗儿童Ⅳ期神经母细胞瘤的近期疗效观察[J].中华血液学杂志,2002,23(2):104-104. 被引量:3
-
3刘晋才.100例舟骨骨折患者的远期随访报告[J].中华手外科杂志,1999,15(3):186-186. 被引量:25
-
4邓爱东,周广鑑.肘管综合征25例远期随访报告[J].伤残医学杂志,2002,10(4):39-40.
-
5胡月,赵强,乔晓红,李杰,李璋琳,王景福,闫杰,曹嫣娜,王会娟.Ⅳ期神经母细胞瘤手术切除范围对生存率的影响[J].中华小儿外科杂志,2013,34(2):81-85. 被引量:4
-
6张敏娜,楼敏.肝透明细胞癌1例远期随访报告[J].人民军医,2014,57(5):565-565.
-
7贾尔同,苗焕哲,王建国.Harrington 手术治疗脊柱骨折脱位75例远期随访报告[J].中华创伤杂志,1995,11(6):349-350.
-
8高解春,金百祥.Ⅲ、Ⅳ期神经母细胞瘤的外科处理:延期和二次手术[J].中华小儿外科杂志,1995,16(2):70-72. 被引量:10
-
9廖孔荣,高伟阳,黄佳温,姜志川.45例肘管综合征术后远期随访报告[J].中华手外科杂志,1997,13(1):32-34. 被引量:14
-
10唐锁勤,黄东生,王建文,冯晨,杨光.大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96. 被引量:27